{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:00:54Z","timestamp":1791302454343,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.pharmthera.2005.06.001","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T20:06:18Z","timestamp":1121198778000},"page":"42-56","source":"Crossref","is-referenced-by-count":71,"title":["Traffic accidents: Molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias"],"prefix":"10.1016","volume":"109","author":[{"given":"Cynthia","family":"Soderblom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Blackstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.06.001_bib1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2004.07.009","article-title":"Seipin: a mysterious protein","volume":"10","author":"Agarwal","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.200304112","article-title":"Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia","volume":"163","author":"Atorino","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s004150050403","article-title":"Troyer syndrome: a combination of central brain abnormality and motor neuron disease?","volume":"246","author":"Auer-Grumbach","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib4","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/emboj\/16.8.1820","article-title":"Endosomal transport function in yeast requires a novel AAA-type ATPase, Vps4p","volume":"16","author":"Babst","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbrc.2004.03.195","article-title":"Identification of nuclear localisation sequences in spastin (SPG4) using a novel Tetra-GFP reporter system","volume":"318","author":"Beetz","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/jnnp.37.1.8","article-title":"Strumpell's familial spastic paraplegia: genetics and neuropathology","volume":"37","author":"Behan","year":"1974","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ana.10768","article-title":"A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24\u2013q32","volume":"54","author":"Blumen","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20416","article-title":"Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28)","volume":"57","author":"Bouslam","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib9","series-title":"Core Text of Neuroanatomy","author":"Carpenter","year":"1991"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0959-437X(00)00199-4","article-title":"Molecular basis of inherited spastic paraplegias","volume":"11","author":"Casari","year":"2001","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)81203-9","article-title":"Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease","volume":"93","author":"Casari","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mcn.2004.01.010","article-title":"Semaphorin3A-induced receptor endocytosis during axon guidance responses is mediated by L1 CAM","volume":"26","author":"Castellani","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/378816","article-title":"Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi\/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons","volume":"73","author":"Chai","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/hmg\/ddg004","article-title":"Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus","volume":"12","author":"Charvin","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/humu.20126","article-title":"Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families","volume":"25","author":"Chen","year":"2005","journal-title":"Human Mutat"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0888-7543(03)00011-9","article-title":"The identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic paraplegia","volume":"81","author":"Ciccarelli","year":"2003","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0960-9822(98)70017-X","article-title":"Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1","volume":"8","author":"Cohen","year":"1998","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(03)00383-1","article-title":"Disruption of cellular transport: a common cause of neurodegeneration","volume":"2","author":"Crosby","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1086\/344206","article-title":"Is the transportation highway the right road for hereditary spastic paraplegia?","volume":"71","author":"Crosby","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/ng1197-346","article-title":"Disruption of the mouse L1 gene leads to malformations of the nervous system","volume":"17","author":"Dahme","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib21","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1212\/01.WNL.0000127698.88895.85","article-title":"Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene","volume":"62","author":"D'Amico","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/11.1.1","article-title":"Disease-associated mutations in L1 CAM interfere with ligand interactions and cell-surface expression","volume":"11","author":"De Angelis","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/mgme.2001.3278","article-title":"OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease","volume":"75","author":"Delettre","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2990.2004.00587.x","article-title":"The extent of axonal loss in the long tracts in hereditary spastic paraplegia","volume":"30","author":"Deluca","year":"2004","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib25","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archneur.61.12.1867","article-title":"Atlastin mutations are frequent in young-onset autosomal dominant spastic paraplegia","volume":"61","author":"D\u00fcrr","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1083\/jcb.200312012","article-title":"Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia","volume":"166","author":"Edgar","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/hmg\/11.2.153","article-title":"Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics","volume":"11","author":"Errico","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib28","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/hmg\/ddh223","article-title":"Spastin interacts with the centrosomal protein NA14 and is enriched in the spindle pole, the midbody, and the distal axon","volume":"13","author":"Errico","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1083\/jcb.200409058","article-title":"Linking axonal degeneration to microtubule remodeling by spastin-mediated microtubule severing","volume":"168","author":"Evans","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/342359","article-title":"Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene","volume":"71","author":"Eymard-Pierre","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1172\/JCI200420138","article-title":"Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport","volume":"113","author":"Ferreirinha","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib32","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/01.WNL.0000138731.60693.D2","article-title":"Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia","volume":"63","author":"Fichera","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00867594","article-title":"Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy","volume":"239","author":"Filla","year":"1992","journal-title":"J Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib34","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/archneur.60.8.1045","article-title":"Hereditary spastic paraplegia: nine genes and counting","volume":"60","author":"Fink","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib35","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.expneurol.2003.08.005","article-title":"Advances in the hereditary spastic paraplegias","volume":"184","author":"Fink","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib36","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archneur.61.6.830","article-title":"Hereditary spastic paraplegia: spastin phenotype and function","volume":"61","author":"Fink","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib37","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/302776","article-title":"A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24\u2013q34","volume":"66","author":"Fontaine","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/6.10.1625","article-title":"L1-associated diseases: clinical geneticists divide, molecular geneticists unite","volume":"6","author":"Fransen","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1749-6632.1999.tb08597.x","article-title":"Peripheral neuropathy caused by proteolipid protein gene mutations","volume":"883","author":"Garbern","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/brain\/awf043","article-title":"Patients lacking the major CNS myelin protein, proteoplipid protein 1, develop length-dependent axonal degeneration in the absence of demyelinatin and inflammation","volume":"125","author":"Garbern","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI20783","article-title":"Synapses and Sisyphus: life without paraplegin","volume":"113","author":"Gelbard","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib42","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1126\/science.280.5369.1610","article-title":"Axonal swellings and degeneration in mice lacking the major proteoplipid of myelin","volume":"280","author":"Griffiths","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ana.10422","article-title":"An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred","volume":"53","author":"Gros-Louis","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/neu.10319","article-title":"Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative diseases","volume":"58","author":"Gunawardena","year":"2003","journal-title":"J Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib45","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/01.CIR.0000038112.64503.6E","article-title":"Cytosolic heat shock protein 60, hypoxia, and apoptosis","volume":"106","author":"Gupta","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng1001-166","article-title":"A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2","volume":"29","author":"Hadano","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib47","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/339935","article-title":"Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60","volume":"70","author":"Hansen","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib48","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","article-title":"Classification of the hereditary ataxias and paraplegias","volume":"1","author":"Harding","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib49","doi-asserted-by":"crossref","first-page":"s1210","DOI":"10.2741\/1108","article-title":"The L1CAM extracellular region: a multi-domain protein with modular and cooperative binding modes","volume":"8","author":"Haspel","year":"2003","journal-title":"Front Biosci"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib50","doi-asserted-by":"crossref","first-page":"33319","DOI":"10.1074\/jbc.M201442200","article-title":"Identification and characterization of RPK118, a novel sphingosine kinase-1-binding protein","volume":"277","author":"Hayashi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/15472","article-title":"Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia","volume":"23","author":"Hazan","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/302258","article-title":"Novel locus for autosomal dominant hereditary spastic paraplegia, on chromosome 8q","volume":"64","author":"Hedera","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tcb.2004.03.009","article-title":"Motor neurons rely on motor proteins","volume":"14","author":"Holzbaur","year":"2004","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/genetics\/135.1.35","article-title":"Loss of function of Saccharomyces cerevisiae kinesin-related CIN8 and KIP1 is suppressed by KAR3 motor domain mutations","volume":"135","author":"Hoyt","year":"1993","journal-title":"Genetics"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib55","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1212\/WNL.56.9.1230","article-title":"SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q","volume":"56","author":"Hughes","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib56","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/genetics\/144.3.1075","article-title":"Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport","volume":"144","author":"Hurd","year":"1996","journal-title":"Genetics"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-004-0207-y","article-title":"PLP1-related inherited dysmyelinating disorders: Pelizaeus\u2013Merzbacher disease and spastic paraplegia type 2","volume":"6","author":"Inoue","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/ng0794-402","article-title":"X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene","volume":"7","author":"Jouet","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/0470093765.ch12","article-title":"Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease)","volume":"264","author":"Julien","year":"2005","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib60","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/hmg\/9.6.879","article-title":"Neural cell recognition molecule L1: relating biological complexity to human disease mutations","volume":"6","author":"Kenwrick","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0896-6273(01)80046-5","article-title":"Assembly of CNS myelin in the absence of proteolipid protein","volume":"18","author":"Klugmann","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib62","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ng0794-351","article-title":"The rumpshaker mutation in spastic paraplegia","volume":"7","author":"Kobayashi","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib63","doi-asserted-by":"crossref","first-page":"38626","DOI":"10.1074\/jbc.M406120200","article-title":"Homo-oligomerization of ALS2 through its unique carboxy-terminal regions is essential for the ALS2-associated Rab5 guanine nucleotide exchange activity and its regulatory function on endosomal trafficking","volume":"279","author":"Kunita","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib64","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/hmg\/ddh263","article-title":"Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis","volume":"13","author":"Lef\u00e8vre","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib65","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0896-6273(89)90048-2","article-title":"L1-mediated axon outgrowth occurs via a homophilic binding mechanism","volume":"2","author":"Lemmon","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0404.1995.tb00430.x","article-title":"Hereditary ataxias and paraplegias in Valle d'Aosta, Italy: a study of prevalence and disability","volume":"91","author":"Leone","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib67","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/01.WNL.0000048207.28790.25","article-title":"Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families","volume":"60","author":"Lesca","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib68","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.ejhg.5200546","article-title":"A refined physical and transcriptional map of the SPG9 locus on 10q23.3\u2013q24.2","volume":"8","author":"Lo Nigro","year":"2000","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jnnp.72.1.43","article-title":"The prevalence of \u201cpure\u201d autosomal dominant hereditary spastic paraparesis in the island of Ireland","volume":"72","author":"Mc Monagle","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib72","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/jnnp.69.2.150","article-title":"Hereditary spastic paraparesis: a review of new developments","volume":"69","author":"McDermott","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/WNL.56.4.467","article-title":"Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England","volume":"56","author":"McDermott","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib70","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ana.10757","article-title":"Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation","volume":"54","author":"McDermott","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib71","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001756-200303030-00038","article-title":"Investigation of mitochondrial function in hereditary spastic paraparesis","volume":"14","author":"McDermott","year":"2003","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib74","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.20239","article-title":"A novel locus for pure recessive hereditary spastic paraplegia maps to 10q22.1\u201310q24.1","volume":"56","author":"Meijer","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.10185","article-title":"Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia","volume":"51","author":"Muglia","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib76","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/hmg\/ddg184","article-title":"ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics","volume":"12","author":"Otomo","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng937","article-title":"SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia","volume":"31","author":"Patel","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib78","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/brain\/114.2.855","article-title":"Hereditary ataxias and paraplegias in Cantabria. Spain: an epidemiological and clinical study","volume":"114","author":"Polo","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib79","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrm1313","article-title":"The dynamin superfamily: universal membrane tubulation and fission molecules","volume":"5","author":"Praefcke","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib80","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1086\/378817","article-title":"NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6)","volume":"73","author":"Rainier","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10048-004-0209-9","article-title":"A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia","volume":"6","author":"Reed","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib82","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1474-4422(03)00345-4","article-title":"Many pathways lead to hereditary spastic paraplegia","volume":"2","author":"Reid","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.40.2.81","article-title":"Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias","volume":"40","author":"Reid","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib86","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/WNL.53.8.1844","article-title":"Autosomal dominant spastic paraplegia: refined SPG8 locus and additional genetic heterogeneity","volume":"53","author":"Reid","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib85","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/302783","article-title":"A locus for autosomal dominant \u201cpure\u201d hereditary spastic paraplegia maps to chromosome 19q13","volume":"66","author":"Reid","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib87","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1086\/344210","article-title":"A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10)","volume":"71","author":"Reid","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/hmg\/ddi003","article-title":"The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B","volume":"14","author":"Reid","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib88","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cub.2005.02.029","article-title":"The Drosophila homologue of the hereditary spastic paraplegia protein, spastin, severs and disassembles microtubules","volume":"15","author":"Roll-Mecak","year":"2005","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-004-0952-x","article-title":"Axonal transport defects: a common theme in neurodegenerative diseases","volume":"109","author":"Roy","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib90","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ng0394-257","article-title":"X-linked spastic paraplegia and Pelizaeus\u2013Merzbacher disease are allelic disorders at the proteolipid protein locus","volume":"6","author":"Saugier-Veber","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib91","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/humu.9205","article-title":"Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus","volume":"23","author":"Sauter","year":"2004","journal-title":"Human Mutat"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib92","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/jmbi.2001.4917","article-title":"Mammalian cells express two VPS4 proteins both of which are involved in intracellular protein trafficking","volume":"312","author":"Scheuring","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib93","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1371\/journal.pbio.0020429","article-title":"Drosophila spastin regulates synaptic microtubule networks and is required for normal motor function","volume":"2","author":"Sherwood","year":"2004","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib94","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0895-4356(97)00202-3","article-title":"Hereditary ataxias and spastic paraplegias: methodological aspects of a prevalence study in Portugal","volume":"50","author":"Silva","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib95","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/379522","article-title":"Maspardin is mutated in Mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia","volume":"73","author":"Simpson","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib96","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/25153","article-title":"Decoupling of nucleotide- and microtubule-binding sites in a kinesin mutant","volume":"396","author":"Song","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib97","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1091\/mbc.E02-08-0468","article-title":"KDEL and KKXX retrieval signals appended to the same reporter protein determine different trafficking between endoplasmic reticulum, intermediate compartment, and Golgi complex","volume":"14","author":"Stornaiuolo","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib98","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/1096-8628(20000904)94:1<5::AID-AJMG2>3.0.CO;2-O","article-title":"Segregation of a pure form of spastic paraplegia and NOR insertion into Xq11.2","volume":"94","author":"Tamagaki","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib99","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/01.WNL.0000036902.21438.98","article-title":"SPG3A: an additional family carrying a new atlastin mutation","volume":"59","author":"Tessa","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib100","doi-asserted-by":"crossref","first-page":"24612","DOI":"10.1074\/jbc.M313504200","article-title":"Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor","volume":"279","author":"Topp","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib101","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cub.2004.06.058","article-title":"The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function","volume":"14","author":"Trotta","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib102","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ana.10204","article-title":"Novel locus for autosomal dominant pure hereditary spastic paraplegia (SPG19) maps to chromosome 9q33\u2013q34","volume":"51","author":"Valente","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib103","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1086\/303017","article-title":"A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27\u2013q28","volume":"67","author":"Vazza","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/humu.1144","article-title":"Genetic and clinical aspects of X-linked hydrocephalus (L1 disease): mutations in the L1CAM gene","volume":"18","author":"Weller","year":"2001","journal-title":"Human Mutat"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib105","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/jnen\/62.11.1166","article-title":"The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene","volume":"62","author":"Wharton","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib107","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.WNL.0000069920.42968.8D","article-title":"A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia","volume":"61","author":"Wilkinson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib108","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-510X(03)00210-7","article-title":"SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia","volume":"216","author":"Wilkinson","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib106","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/brain\/awh125","article-title":"A clinical, genetic, and biochemical study of SPG7 mutations in hereditary spastic paraplegia","volume":"127","author":"Wilkinson","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib109","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/jmg.2004.020172","article-title":"A new locus for autosomal recessive complicated hereditary spastic paraplegia (SPG26) maps to chromosome 12p11.1\u201312q14","volume":"42","author":"Wilkinson","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ng1313","article-title":"Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome","volume":"36","author":"Windpassinger","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib111","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archneur.61.1.117","article-title":"Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11)","volume":"61","author":"Winner","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib112","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1083\/jcb.200301026","article-title":"Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A","volume":"161","author":"Xia","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib113","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ng1001-160","article-title":"The gene encoding alsin, a protein with three guanine\u2013nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis","volume":"29","author":"Yang","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib114","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/hmg\/9.6.987","article-title":"The proteolipid protein gene and myelin disorders in man and animal models","volume":"9","author":"Yool","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib115","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1091\/mbc.11.2.747","article-title":"The mouse SKD1, a homologue of yeast Vps4p, is required for normal endosomal trafficking and morphology in mammalian cells","volume":"11","author":"Yoshimori","year":"2000","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib116","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1093\/emboj\/20.11.2611","article-title":"A structural pathway for activation of the kinesin motor ATPase","volume":"20","author":"Yun","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib117","doi-asserted-by":"crossref","first-page":"9123","DOI":"10.1074\/jbc.M009270200","article-title":"Cloning of ACP33 as a novel intracellular ligand of CD4","volume":"276","author":"Zeitlmann","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib118","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/ncb1001-922","article-title":"Three-dimensional reconstruction of dynamin in the constricted state","volume":"3","author":"Zhang","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib119","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng758","article-title":"Mutations in a novel GTPase cause autosomal dominant hereditary spastic paraplegia","volume":"29","author":"Zhao","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib120","doi-asserted-by":"crossref","first-page":"49063","DOI":"10.1074\/jbc.M306702200","article-title":"Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin","volume":"278","author":"Zhu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib121","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/jmg.39.6.387","article-title":"Genetic mapping of a susceptibility locus for disc herniation and spastic paraplegia on 6q23.3\u2013q24.1","volume":"39","author":"Zortea","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.06.001_bib122","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot\u2013Marie\u2013Tooth neuropathy type 2A","volume":"36","author":"Z\u00fcchner","year":"2004","journal-title":"Nat Genet"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T12:26:49Z","timestamp":1626179209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725805001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":122,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0163725805001208"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.06.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}